Refractoriness to eltrombopag in adult primary immune thrombocytopenia: utility of next-generation sequencing techniques.
Saved in:
| Title: | Refractoriness to eltrombopag in adult primary immune thrombocytopenia: utility of next-generation sequencing techniques. |
|---|---|
| Authors: | González-López TJ; Department of Hematology, Hospital Universitario de Burgos, Burgos, Spain., Sanchez R; Department of Hematology, Hospital Universitario 12 de Octubre, Madrid, Spain., Pastoriza C; Department of Hematology, Complexo Hospitalario Universitario de Ourense, Ourense, Spain., Olivera P; Department of Hematology, Hospital Universitario Vall d'Hebron, Barcelona, Spain., Bernat S; Department of Hematology, Hospital Universitario de La Plana, Villarreal, Spain., Fernandez-Fuertes F; Department of Hematology, Complejo Hospitalario Universitario Insular Materno-Infantil, Las Palmas de Gran Canaria, Spain., Caparrós-Miranda IS; Department of Hematology, Hospital Universitario Virgen de la Victoria, Malaga, Spain., Pérez-Rus G; Department of Hematology, Hospital Universitario Gregorio Marañón de Madrid, Madrid, Spain., Jarque I; Department of Hematology, Hospital Universitario y Politécnico La Fe de Valencia, Valencia, Spain., Moreno-Beltrán ME; Department of Hematology, Hospital Costa del Sol, Marbella, Spain., López-Abadía E; Department of Hematology, Hospital General de Elche, Elche, Spain., De Cabo E; Department of Hematology, Complejo Hospital de El Bierzo, Ponferrada, Spain., Marcellini S; Department of Complejo Asistencial de Segovia, Segovia, Spain., Pérez-Segura G; Department of Hematology, Hospital Universitario 12 de Octubre, Madrid, Spain., Fernández-Miñano C; Department of Hematology, Hospital Vega Baja, Orihuela, Spain., Peñarrubia MJ; Department of Hematology, Hospital Clínico Universitario de Valladolid, Valladolid, Spain., Matarraz S; Translational and Clinical Research Program, Centro de Investigación del Cáncer (Instituto Universitario de Biología Molecular y Celular del Cáncer; Consejo Superior de Investigaciones Científicas-University of Salamanca); Servicio de Apoyo a la Investigación NUCLEUS; Department of Medicine, University of Salamanca and Institute of Biomedical Research of Salamanca, Salamanca, Spain.; Biomedical Research Networking Centre Consortium of Oncology (Centro de Investigación Biomédica en Red Cáncer), Instituto de Salud Carlos III, Madrid, Spain., Pérez-Caro M; Banco Nacional de ADN, Universidad de Salamanca, Salamanca, Spain., Orfao A; Translational and Clinical Research Program, Centro de Investigación del Cáncer (Instituto Universitario de Biología Molecular y Celular del Cáncer; Consejo Superior de Investigaciones Científicas-University of Salamanca); Servicio de Apoyo a la Investigación NUCLEUS; Department of Medicine, University of Salamanca and Institute of Biomedical Research of Salamanca, Salamanca, Spain.; Biomedical Research Networking Centre Consortium of Oncology (Centro de Investigación Biomédica en Red Cáncer), Instituto de Salud Carlos III, Madrid, Spain.; Banco Nacional de ADN, Universidad de Salamanca, Salamanca, Spain.; Biomedical Research Institute of Salamanca, Salamanca, Spain., Provan D; Department of Haematology, Barts & The London School of Medicine, London, United Kingdom., Martínez-López J; Department of Hematology, Hospital Universitario 12 de Octubre, Madrid, Spain.; Department of Medicine, Universidad Complutense, Madrid, Spain.; Spanish Center of Oncology Research, Madrid, Spain. |
| Source: | Blood vessels, thrombosis & hemostasis [Blood Vessel Thromb Hemost] 2025 Feb 17; Vol. 2 (3), pp. 100061. Date of Electronic Publication: 2025 Feb 17 (Print Publication: 2025). |
| Publication Type: | Journal Article |
| Journal Info: | Publisher: Elsevier Inc Country of Publication: United States NLM ID: 9918957761606676 Publication Model: eCollection Cited Medium: Internet ISSN: 2950-3272 (Electronic) Linking ISSN: 29503272 NLM ISO Abbreviation: Blood Vessel Thromb Hemost Subsets: PubMed not MEDLINE |
| Database: | MEDLINE Ultimate |
Be the first to leave a comment!
